Vyera Pharmaceuticals is focused on developing therapies specifically targeted to treat patients suffering from serious and neglected diseases with high unmet needs. One of Vyera’s areas of focus is toxoplasmosis. Vyera provides support to programs that assist patients who may have difficulty affording their treatment and gives discounts to organizations that provide care to underserved patients. Toxoplasmosis is considered ...
Vyera Pharmaceuticals is focused on developing therapies specifically targeted to treat patients suffering from serious and neglected diseases with high unmet needs. One of Vyera’s areas of focus is toxoplasmosis. Vyera provides support to programs that assist patients who may have difficulty affording their treatment and gives discounts to organizations that provide care to underserved patients. Toxoplasmosis is considered a neglected parasitic infection that has been targeted as a priority for public health.
Vyera's discovery program is identifying novel drug candidates in hopes of creating a treatment.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.